Citius Pharmaceuticals, Inc. (CTXR) Reports Material Event to SEC
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) filed a Form 8-K with the Securities and Exchange Commission on March 04, 2026, disclosing a material event. Citius Pharmaceuticals,…
Read more
